[Federal Register: July 25, 2006 (Volume 71, Number 142)]
[Notices]
[Page 42098]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jy06-54]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Nonprescription Drugs Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Nonprescription Drugs Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on September 25, 2006, from
8 a.m. to 5 p.m.
Location: Hilton Hotel Washington DC North/Gaithersburg, The
Ballrooms, 620 Perry Pkwy., Gaithersburg, MD. The hotel phone number is
301-977-8900.
Contact Person: Darrell Lyons, Center for Drug Evaluation and
Research (HFD 21), Food and Drug Administration, 5600 Fishers Lane (for
express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857,
301-827-7001, FAX: 301-827-6778, e-mail: lyonsd@cder.fda.gov or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area) code 3014512541. Please call the Information
Line for up to date information on this meeting.
Agenda: The committee will consider issues related to the analysis
and interpretation of consumer behavior studies conducted to support
marketing of nonprescription drug products. The background material
will become available no later than the day before the meeting and will
be posted under the Nonprescription Drugs Advisory Committee (NDAC)
docket site at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. (Click
on the year 2006 and scroll down to NDAC meetings.)
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
September 11, 2006. Oral presentations from the public will be
scheduled between approximately 1 p.m. and 2 p.m. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their presentation
before September 11, 2006.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Darrell Lyons at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: July 17, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-11774 Filed 7-24-06; 8:45 am]
BILLING CODE 4160-01-S